Manipal Health Enterprises (BOM:544847) EBIT: ₹ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544847 Manipal Health Enterprises Ltd BOM:544847
13 GF Score
Price ₹771.85
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises EBIT?

Manipal Health Enterprises BOM:544847 -3.22% 13 EBIT is ₹ Mil as of Mar. 2026. GuruFocus rates BOM:544847 with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Manipal Health Enterprises's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹21,141 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Manipal Health Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 was 6.98%. Manipal Health Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 24.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Manipal Health Enterprises  (BOM:544847) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Manipal Health Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=19958.16 * ( 1 - 28.63% )/( (187232 + 220941.13)/ 2 )
=14244.138792/204086.565
=6.98 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=214438.1 - 14018.89 - ( 30968.38 - max(0, 27345.44 - 40532.65+30968.38))
=187232

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=248645.03 - 20237.66 - ( 28109.15 - max(0, 33623.72 - 41089.96+28109.15))
=220941.13

Note: The Operating Income data used here is one times the annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Manipal Health Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=21140.71/( ( (79097.96 + max(-14083.13, 0)) + (90310.48 + max(-14216.46, 0)) )/ 2 )
=21140.71/( ( 79097.96 + 90310.48 )/ 2 )
=21140.71/84704.22
=24.96 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7319.69 + 1504.01 + 706.73) - (14018.89 + 0 + 9594.67)
=-14083.13

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9297.59 + 1698.51 + 1572.73) - (20237.66 + 0 + 6547.63)
=-14216.46

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Manipal Health Enterprises's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=/1119258.998
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises EBIT Related Terms

Manipal Health Enterprises EBIT Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises EBIT Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
EBIT
11,498.42 18,734.57 21,140.71

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
EBIT 11,498.42 18,734.57 21,140.71

BOM:544847 vs HCA, THC, EHC: EBIT Comparison

For the Medical Care Facilities subindustry, Manipal Health Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Manipal Health Enterprises EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Manipal Health Enterprises's EV-to-EBIT falls into.


BOM:544847
13GF Score
Manipal Health Enterprises Ltd BOM:544847
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹ Mil mean?
Manipal Health Enterprises (BOM:544847) has a EBIT of ₹ Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Manipal Health Enterprises.
Is Manipal Health Enterprises' EBIT too high?
Manipal Health Enterprises' current EBIT is ₹ Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' EBIT compare to HCA and THC?
Manipal Health Enterprises' EBIT of ₹ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Manipal Health Enterprises. Manipal Health Enterprises's current EBIT is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (BOM:544847) has a current EBIT of ₹ Mil. The current EBIT is ₹ Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Manipal Health Enterprises (BOM:544847), the current EBIT is ₹ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Other Exchanges MANIPALHOS:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for BOM:544847

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.85
Price